Lake Street Private Wealth LLC Acquires 327 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Lake Street Private Wealth LLC lifted its holdings in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 3.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,980 shares of the biotechnology company's stock after acquiring an additional 327 shares during the period. Lake Street Private Wealth LLC's holdings in Axon Enterprise were worth $5,249,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Fourth Dimension Wealth LLC acquired a new stake in Axon Enterprise during the fourth quarter worth about $30,000. Y.D. More Investments Ltd acquired a new stake in Axon Enterprise during the fourth quarter worth about $45,000. Elequin Capital LP acquired a new stake in Axon Enterprise during the fourth quarter worth about $46,000. Stonebridge Financial Group LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $53,000. Finally, CoreFirst Bank & Trust acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at approximately $59,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research analyst reports. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Needham & Company LLC raised their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Northcoast Research downgraded shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Barclays raised their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Finally, Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Trading Up 0.4%

Axon Enterprise stock traded up $3.49 during mid-day trading on Friday, hitting $791.85. 443,537 shares of the stock were exchanged, compared to its average volume of 731,575. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $278.24 and a 12 month high of $798.16. The firm's fifty day simple moving average is $643.89 and its two-hundred day simple moving average is $616.38. The stock has a market capitalization of $61.65 billion, a price-to-earnings ratio of 204.61, a PEG ratio of 5.17 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The firm had revenue of $603.63 million during the quarter, compared to analyst estimates of $585.67 million. During the same quarter last year, the business earned $1.15 EPS. The company's revenue was up 31.3% compared to the same quarter last year. Analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Insider Activity

In other news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael Garnreiter sold 87 shares of Axon Enterprise stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $760.00, for a total transaction of $66,120.00. Following the completion of the sale, the director now owns 24,653 shares of the company's stock, valued at $18,736,280. This represents a 0.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,969 shares of company stock worth $29,909,594 in the last quarter. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.